A Framework Proposal for Quality and Safety Measurement in Gynecologic Emergency Care.


Journal

Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 9 10 2020
medline: 1 12 2020
entrez: 8 10 2020
Statut: ppublish

Résumé

To define and assess the prevalence of potentially life-threatening gynecologic emergencies among women presenting for acute pelvic pain for the purpose of developing measures to audit quality of care in emergency departments. We conducted a mixed-methods multicenter study at gynecologic emergency departments in France and Belgium. A modified Delphi procedure was first conducted in 2014 among health care professionals to define relevant combinations of potentially life-threatening conditions and near misses in the field of gynecologic emergency care. A prospective case-cohort study in the spring of 2015 then assessed the prevalence of these potentially life-threatening emergencies and near misses among women of reproductive age presenting for acute pelvic pain. Women in the case group were identified at 21 participating centers. The control group consisted of a sample of women hospitalized for acute pelvic pain not caused by a potentially life-threatening condition and a 10% random sample of outpatients. Eight gynecologic emergencies and 17 criteria for near misses were identified using the Delphi procedure. Among the 3,825 women who presented for acute pelvic pain, 130 (3%) were considered to have a potentially life-threatening condition. The most common diagnoses were ectopic pregnancies with severe bleeding (n=54; 42%), complex pelvic inflammatory disease (n=30; 23%), adnexal torsion (n=20; 15%), hemorrhagic miscarriage (n=15; 12%), and severe appendicitis (n=6; 5%). The control group comprised 225 hospitalized women and 381 outpatients. Diagnostic errors occurred more frequently among women with potentially life-threatening emergencies than among either hospitalized (odds ratio [OR] 1.7, 95% CI 1.1-2.7) or outpatient (OR 14.7, 95% CI 8.1-26.8) women in the control group. Of the women with potentially life-threatening conditions, 26 met near-miss criteria compared with six with not potentially life-threatening conditions (OR 25.6, 95% CI 10.9-70.7). Potentially life-threatening gynecologic emergencies are high-risk conditions that may serve as a useful framework to improve quality and safety in emergency care.

Identifiants

pubmed: 33030878
doi: 10.1097/AOG.0000000000004132
pmc: PMC7575026
pii: 00006250-202011000-00009
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

912-921

Références

JAMA. 2015 Dec 15;314(23):2501-2
pubmed: 26571126
Natl Health Stat Report. 2010 Aug 6;(26):1-31
pubmed: 20726217
Lancet. 2004 Mar 27;363(9414):1061-7
pubmed: 15051287
Med Care. 1995 Jan;33(1):75-89
pubmed: 7823649
Best Pract Res Clin Obstet Gynaecol. 2006 Oct;20(5):729-50
pubmed: 16824800
Br J Clin Pharmacol. 2009 Jun;67(6):651-5
pubmed: 19594533
Jt Comm J Qual Patient Saf. 2016 Nov;42(11):516-527
pubmed: 28266920
BMJ Qual Saf. 2013 Oct;22 Suppl 2:ii21-ii27
pubmed: 23771902
J R Soc Med. 2001;94 Suppl 39:16-9
pubmed: 11383423
J Am Med Inform Assoc. 2004 Nov-Dec;11(6):468-78
pubmed: 15298992
Am J Obstet Gynecol. 2011 Jan;204(1):5-10
pubmed: 21187195
Milbank Mem Fund Q. 1966 Jul;44(3):Suppl:166-206
pubmed: 5338568
Eur J Obstet Gynecol Reprod Biol. 2010 May;150(1):8-12
pubmed: 20189289
Soc Sci Med. 1994 Apr;38(8):1091-110
pubmed: 8042057
J Emerg Med. 1990 Jul-Aug;8(4):441-7
pubmed: 2212563
Lancet. 2016 Oct 8;388(10053):1775-1812
pubmed: 27733286
Fertil Steril. 2012 Mar;97(3):623-9
pubmed: 22264999
J Pediatr Adolesc Gynecol. 2008 Oct;21(5):295-7
pubmed: 18794026
BMJ. 2000 Mar 18;320(7237):777-81
pubmed: 10720366
Am J Emerg Med. 1990 Nov;8(6):515-22
pubmed: 2222596
Surg Clin North Am. 2008 Apr;88(2):265-83, vi
pubmed: 18381113
PLoS One. 2011;6(6):e20476
pubmed: 21694759
Postgrad Med J. 2011 Apr;87(1026):245-50
pubmed: 21310804
Obstet Gynecol. 2009 Feb;113(2 Pt 1):260-9
pubmed: 19155893
Best Pract Res Clin Obstet Gynaecol. 2009 Jun;23(3):287-96
pubmed: 19303368
Ultrasound Obstet Gynecol. 2010 Mar;35(3):344-8
pubmed: 20069669
Am J Obstet Gynecol. 2001 May;184(6):1149-55
pubmed: 11349181
Health Technol Assess. 2002;6(1):1-78
pubmed: 11809128
World J Emerg Surg. 2014 Aug 13;9:46
pubmed: 25180047
Best Pract Res Clin Obstet Gynaecol. 2009 Oct;23(5):679-90
pubmed: 19596611
J Epidemiol Community Health. 2013 Nov 1;67(11):974-8
pubmed: 23963506

Auteurs

Arnaud Fauconnier (A)

Université Paris-Saclay, UVSQ, Unité de recherche 7285, Risques cliniques et sécurité en santé des femmes et en santé périnatale (RISCQ), Montigny-le-Bretonneux, Centre Hospitalier Intercommunal de Poissy-Saint-Germain-en-Laye, Service de gynecologie & obstétrique, Poissy, Université Paris Diderot, Sorbonne Paris Cité, AP-HP; Inserm, Hôpital Robert Debré, Unité d'Epidémiologie Clinique, Paris, Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, Clermont-Ferrand, AUDIPOG, Université Claude Bernard Lyon 1, Laennec, Lyon, Service de Gynécologie Obstétrique, Hôpital Femme Mère Enfant, Hospices Civils de Lyon, Lyon, Service de Gynécologie Obstétrique Hôpital Lariboisière, Paris, Service de Gynécologie Obstétrique Hôpital Jeanne de Flandre CHRU, Lille, Service de Gynécologie Obstétrique CHI de Villeneuve-Saint-Georges, Villeneuve Saint-Georges, Service de Gynécologie, Obstétrique et Médecine de la Reproduction, CHU Cochin Paris, Université Paris Descartes, Paris Sorbonne Cité, Paris, Gynécologie chirurgicale, CHU de Rennes, Rennes, Service de gynécologie-obstétrique, hôpitaux de Nantes, CHU Hôtel-Dieu, Nantes, Université de Nantes, Nantes, Service de Gynécologie Obstétrique, hôpital de La Conception, Assistance publique-Hôpitaux de Marseille, Marseille, Service de gynécologie obstétrique, Hôpital Bichat, APHP, Paris, Université Diderot Paris, Paris, Unité de recherche EA 7285, Université Versailles St-Quentin (UVSQ), Montigny-le-Bretonneux, Centre Hospitalier Universitaire Hautepierre, Hôpital de Hautepierre, Strasbourg, Département de l'assurance qualité, de la gestion des risques et des droits du patient, hôpitaux Universitaires de Paris Nord Val de Seine, APHP, Paris, Unité d'Epidémiologie Clinique, URC Robert Debré, APHP, Paris, Inserm CIC-EC 1426; Inserm et Université Paris Diderot UMR 1123 ECEVE, Paris, Paris, Institut de recherche pour le développement (IRD), université Paris Descartes, UMR 196, CEPED, Paris, UMR 1153 Equipe EPOPé, INSERM, Paris, France; and CHR la Citadelle, Université de Liège, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH